Quick Answer
Curanex Pharmaceuticals Inc reported R&D Expense of $2.99 million for fiscal year 2025.
Curanex Pharmaceuticals Inc R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $2.99M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $677.5K | — | — |
- The most recent figure is from Curanex Pharmaceuticals Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: